Johnson Financial Group Inc (Wisconsin)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.2K Buy
+142
New +$31.1K ﹤0.01% 516
2024
Q3
– Sell
-8
Closed -$854 – 979
2024
Q2
$854 Buy
+8
New +$880 ﹤0.01% 759
2024
Q1
– Sell
-3
Closed -$369 – 889
2023
Q4
$369 Buy
+3
New +$374 ﹤0.01% 848
2013
Q3
– Sell
-84
Closed -$6K – 690
2013
Q2
$6K Buy
+84
New +$5.13K ﹤0.01% 603

Other funds holding JAZZ

Johnson Financial Group Inc (Wisconsin)'s JAZZ Position: Q2 2026 in Review

Johnson Financial Group Inc (Wisconsin) opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 142 shares worth $34.2K. The stake represents ﹤0.01% of the portfolio and ranks #516 among its holdings. This is a return to the name: Johnson Financial Group Inc (Wisconsin) previously reported a position in JAZZ as recently as Q2 2024.

Johnson Financial Group Inc (Wisconsin) first reported a position in JAZZ in Q2 2013 and has held it in 4 quarters since. 649 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Johnson Financial Group Inc (Wisconsin) held 142 shares of Jazz Pharmaceuticals worth $34.2K as of Q2 2026.
  • Jazz Pharmaceuticals was a new Johnson Financial Group Inc (Wisconsin) position in Q2 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q2 2026, its #516 holding.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 4 quarters since.
  • 649 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.